You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial

Article metrics

Article menu

Download PDFPDF

Oral Presentations
Vasculitis clinical and pathogenic highlights
OP0130 Mepolizumab for the treatment of patients with eosinophilic granulomatosis with polyangiitis: a phase iii randomised, placebo-controlled trial
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20173602
Jul 20173003
Aug 20173606
Sep 20173604
Oct 20171602
Nov 20176801
Dec 20173202
Jan 20185405
Feb 20184400
Mar 20184000
Apr 20185401
May 20187603
Jun 20184401
Jul 20184401
Aug 20183000
Sep 201834011
Oct 20184604
Nov 20185209
Dec 20182805
Jan 20193406
Feb 20193005
Mar 20193409
Apr 2019805
May 20191208
Jun 2019805
Jul 20191807
Aug 20191606
Sep 20191606
Oct 20191605
Nov 2019404
Dec 20191003
Jan 20201002
Feb 20201205
Mar 20201003
Apr 2020002
May 20201002
Jun 2020802
Jul 2020602
Aug 2020003
Sep 20201000
Oct 2020002
Nov 2020402
Dec 2020400
Jan 2021002
Feb 2021204
Mar 2021204
Apr 2021201
May 2021201
Jul 2021006
Aug 2021001
Sep 2021001
Oct 20214015
Nov 20212013
Dec 2021603
Jan 2022600
Feb 2022402
Mar 2022201
Apr 2022300
May 20221007
Jun 20221402
Jul 20222204
Aug 2022805
Sep 2022205
Oct 2022404
Nov 2022404
Dec 20221000
Jan 2023601
Feb 2023401
Mar 20231202
Apr 2023203
May 2023003
Jun 2023401
Jul 2023206
Aug 2023201
Sep 2023201
Oct 2023002
Nov 2023002
Dec 20231801
Jan 2024203
Feb 2024202
Mar 2024201
Total12470269